MRNA
Moderna, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #131
- Final score
- 64.17
- Years on list
- 7
↗ Climbed 447 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 447 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 85 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 177 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | MRNA | ABBV | WAT |
|---|---|---|---|
| Climate Change | 79.3 | 73.5 | 75.8 |
| Employee Relations | 61.6 | 62.5 | 58.4 |
| Environment | 47.1 | 65.1 | 63.7 |
| Stakeholders & Society | 76.7 | 65.2 | 79.3 |
| Human Rights | 55.1 | 57.9 | 46.9 |
| Governance | 59.9 | 60.2 | 48.2 |
| Performance Rating | 65.5 | 68.1 | 53.1 |